The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
You are here: Home / Pfizer RSV vaccine that protects infants could receive FDA approval this summer
Market News and Views
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.